Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
Titel:
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
Auteur:
Verschraegen, C.F. Arias-Pulido, H. Lee, S.-J. Movva, S. Cerilli, L.A. Eberhardt, S. Schmit, B. Quinn, R. Muller, C.Y. Rabinowitz, I. Purdy, M. Snyder, D. Bocklage, T.